French company will set up a production of innovative medicines in Kazakhstan

| By | Kazakhstan, Localization, Servier, Technology transfer

At the meeting on global investments held in Astana, the companies of Kazakhstan signed 32 commercial documents for the total amount of $4.7 billion.

Kazakhstan Global Investment Roundtable (KGIR-2018) brought together more than 600 heads of the world’s largest companies and representatives of local businesses.

Kazakh Invest, a company, signed a number of MoUs, including the agreements with French companies which plan to establish a pharmaceutical production facility and retail chain for sports clothing and equipment, and later localize the manufacturing. The project is estimated at $300 million, and it will create 4800 new jobs.

According to the reports, earlier, Kazakh Prime Minister Bakytzhan Sagintayev held a number of meetings with the participants of KGIR-2018. During the meeting with Jérôme Gavet, Managing Director of Servier in Russia and EAEU, the parties discussed investments and technology transfer for manufacturing innovative medicines in Kazakhstan.

Servier opened a representative office in Kazakhstan in 1996 to sell its medicinal products and support Kazakhstan’s distributors to supply medicines manufactured by the company.